当前位置:首页 - 行情中心 - 千红制药(002550) - 财务分析

千红制药

(002550)

  

流通市值:66.36亿  总市值:90.23亿
流通股本:9.41亿   总股本:12.80亿

千红制药(002550)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.84亿元,每股收益0.07元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益285205.02万元,未分配利润133277.37万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产323186.63万元,负债37981.60万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入358,078,398.611,571,276,512.221,215,015,041.44861,771,495.13
营业总成本265,121,901.261,260,212,744.09918,885,764.41638,132,988.95
其他经营收益
营业利润102,730,876.29455,631,141.11438,145,315.92293,324,555.85
利润总额102,799,988.74450,181,945.86437,798,686.06293,100,039.59
净利润84,497,588.87373,254,947.94368,133,628.6249,582,175.18
每股收益
其他综合收益-1,441,250.691,869,290.37397,763.3207,912.65
综合收益总额83,056,338.18375,124,238.31368,531,391.9249,790,087.83
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计2,028,720,806.381,909,727,729.21,937,455,509.211,805,456,695.2
非流动资产:
非流动资产合计1,203,145,443.941,178,445,247.291,078,032,976.51,066,614,748.8
资产总计3,231,866,250.323,088,172,976.493,015,488,485.712,872,071,444
流动负债:
流动负债合计278,061,295.18225,520,207.63163,707,947.23163,921,881.65
非流动负债:
非流动负债合计101,754,740.2796,433,892.1792,154,508.291,764,836.14
负债合计379,816,035.45321,954,099.8255,862,455.43255,686,717.79
所有者权益(或股东权益):
归属于母公司股东权益合计2,854,288,442.662,767,899,632.162,750,858,850.382,625,725,037.86
股东权益合计2,852,050,214.872,766,218,876.692,759,626,030.282,616,384,726.21
负债和股东权益合计3,231,866,250.323,088,172,976.493,015,488,485.712,872,071,444
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计452,528,076.721,735,369,559.381,306,790,650.77819,743,524.9
经营活动现金流出小计314,268,879.151,374,008,106.261,015,443,917.05673,907,343.46
经营活动产生的现金流量净额138,259,197.57361,361,453.12291,346,733.72145,836,181.44
投资活动产生的现金流量:
投资活动现金流入小计442,861,502.03346,844,940.791,276,176,156.46920,739,417.79
投资活动现金流出小计436,069,394.87509,186,059.831,417,678,290.07740,561,517.94
投资活动产生的现金流量净额6,792,107.16-162,341,119.04-141,502,133.61180,177,899.85
筹资活动产生的现金流量:
筹资活动现金流入小计46,126,37532,757,48024,500,000-
筹资活动现金流出小计-170,434,116.81170,929,352.81151,437,240.79
筹资活动产生的现金流量净额46,126,375-137,676,636.81-146,429,352.81-151,437,240.79
汇率变动对现金及现金等价物的影响-1,915,895.88-13,051,061.63-4,075,986.45-1,137,744.46
现金及现金等价物净增加额189,261,783.8548,292,635.64-660,739.15173,439,096.04
期末现金及现金等价物余额677,499,819.5488,238,035.65439,284,660.86613,384,496.05
补充资料:
现金及现金等价物的净增加额-48,292,635.64-173,439,096.04
最新报告期:2026-05-07
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
东海证券付婷,杜永宏0.270.300.332026-05-07
TOP↑